BPA Call 36C25524A0025-36C25525N0282

Award Date 3/28/25
Potential Completion Date 7/31/25
Potential Value $266K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Millburn, NJ 07041, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,987,496.80 firm-fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract is for the supply of PLUVICTO (Lutetium Lu 177 Vipivotide Tetraxetan), a radiopharmaceutical product used in cancer treatment and diagnostic imaging. The contract was awarded under the Pharmaceuticals and Drugs Federal Supply...
This federal contract award is for a Blanket Purchase Agreement (BPA) call with Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract is being administered by the Veterans Integrated Service Network 2, a civilian agency within the Department of Veterans Affairs (VA). The award is for the radiopharmaceutical product PLUVICTO (lutetium Lu 177 vipivotide tetraxetan), which is used for cancer...
This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract, with a ceiling value of $1,960,519.26, is for the supply of the radiopharmaceutical drug PLUVICTO (lutetium Lu 177 vipivotide tetraxetan) to the VA's Integrated Service Network 9. The contract is a Blanket Purchase Agreement (BPA) call under the...
This federal contract award is for the delivery of the radiopharmaceutical products Lutetium Lu 177 LUTATHERA and PLUVICTO to the Veterans Integrated Service Network 10 (VISN 10) of the U.S. Department of Veterans Affairs (VA). The contract has a total ceiling value of $1,956,064.53 and an ultimate completion date of December 31, 2023. It was awarded on January 1, 2023 to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear...
This is a firm fixed price BPA call order awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer of goods. The contract is for the delivery of the radiopharmaceutical product PLUVICTO (Lutetium Lu 177 Vipivotide Tetraxetan) with a potential value of $746,610.13 and a completion date of March 27, 2025. Advanced Accelerator Applications USA Inc. is a...
This federal contract award was issued by the Veterans Integrated Service Network 15 (VISN 15), a division of the U.S. Department of Veterans Affairs (VA), to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The $1,493,266.26 Blanket Purchase Agreement (BPA) call contract is for the procurement of the radiopharmaceuticals PLUVICTO and LUTATHERA, which are used in cancer treatment and diagnostic imaging....
This is a $462,715.00 firm fixed price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer of radiopharmaceuticals. The contract is for the delivery of various radiopharmaceutical products including Lutetium Lu 177 Dotatate, Lutetium Lu 177 Vipivotide Tetraxetan, gallium Ga 68 dotatate, and Ga-68 Dotatate injections to VA medical centers and integrated service...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $349,600 firm fixed price delivery order to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is for the provision of radiopharmaceutical products such as Lutetium Lu 177 Dotatate, Lutetium Lu 177 Vipivotide Tetraxetan, gallium Ga 68 dotatate, and Ga-68 Dotatate injections to VA medical centers and...
This is a federal contract award to Advanced Accelerator Applications USA Inc., a subsidiary of Novartis, for the delivery of the radiopharmaceutical product PLUVICTO. The contract, valued at $2,979,818.10, is a delivery order awarded by the Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract has an ultimate completion date of October 31, 2025. This award is not set aside for small businesses. Advanced Accelerator Applications...
This $2,356,913.50 federal contract was awarded by the Veterans Integrated Service Network 10 (VISN 10), a division of the U.S. Department of Veterans Affairs (VA), to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract is for the delivery of PLUVICTO and LUTATHERA, two specialized radiopharmaceutical products used in cancer treatment and diagnostic imaging. The contract is a Delivery Order under...

This federal contract award is for the provision of PLUVICTO (lutetium Lu 177 vipivotide tetraxetan), a radiopharmaceutical product used in targeted radioligand therapy and nuclear medicine procedures. The contract was awarded to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products, operating as a subsidiary of Novartis.

The contract was awarded by the Department of Veterans Affairs (VA), specifically through the Veterans Integrated Service Network 15 (VISN 15), and is a Blanket Purchase Agreement (BPA) call under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract has a ceiling value of $265,833.12 and a period of performance through July 31, 2025. The contract is not set aside for small businesses.

Generated 4/22/25, 12:03 PM